Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pembrolizumab and Epacadostat in Thymic Carcinomas
NCT02364076Phase 2Unknown
- Sponsor
- Georgetown University
- Start
- Mar 2015
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epacadostat in thymic carcinoma (TC), sponsored by Georgetown University. Status: unknown.
02
Drugs
epacadostat
03
Conditions
thymic carcinoma (TC)
Beyond the preview
Go deeper on NCT02364076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02364076.